Expression cloning and characterization of the canine parietal cell gastrin receptor.
about
Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptorsHuman colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growthCloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YYInhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAsPost-poly(Glu) cleavage and degradation modified by O-sulfated tyrosine: a novel post-translational processing mechanismAcid secretion and the H,K ATPase of stomachPharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cellsMobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious ratsG protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivoIntracellular signal transduction during gastrin-induced histamine secretion in rat gastric ECL cellsCholecystokinin Stimulates Ca2+Mobilization and Clonal Growth in Small Cell Lung Cancer through CCKAand CCKB/Gastrin ReceptorsThe Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.Gastrin decreases Na+,K+-ATPase activity via a PI 3-kinase- and PKC-dependent pathway in human renal proximal tubule cells.Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger.Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human.Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection.Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells.Topical review. Gastrin and gastric epithelial physiology.Properties of isolated gastric enterochromaffin-like cells.Relationship of ECL cells and gastric neoplasiaA network map of the gastrin signaling pathway.Personal review: is profound acid inhibition safe?Cholecystokinin and pancreatic cancer: the chicken or the egg?Modulation of cholecystokinin activity by albuminMechanism of gastric mucosal proliferation induced by gastrin.Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivoCholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.Measurement of nonsulfated cholecystokinins.Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.Regulation of histamine release from oxyntic mucosa.Gastrointestinal satiety signals II. Cholecystokinin.Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.Novel approaches to the pharmacological blockade of gastric acid secretion.A Transcriptome-Led Exploration of Molecular Mechanisms Regulating Somatostatin-Producing D-Cells in the Gastric Epithelium.CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis.Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug.Sensitivity of cholecystokinin receptors to membrane cholesterol content.
P2860
Q22010243-A5D1D6BC-B3DE-43A3-9F4E-8EDD19064E04Q22254675-47B1A7EA-19A4-4592-AE80-73C952A82719Q24304140-5BD4DDA5-4F6C-45BC-90AD-62CDC1F8502CQ24552584-A1B8A92F-4D8F-460D-BD76-F69B58015CF1Q24564721-96946812-D376-4FBB-9E9B-6BFEAB1F1302Q24568362-D1306F91-EB0E-42FB-BC90-309FCE480F73Q28214032-AA236B99-2274-4A0A-A88F-2CA77B8C4BEBQ28343413-2FA82387-B906-41D5-8903-DFA4AF22B4FAQ28363788-E2B664FB-5BEC-4947-B1F6-88AC326E98AFQ28512542-518690FF-A9EC-4F97-8287-AC36C2150927Q28570748-FC3B2C3E-B990-402A-BA51-E9E695EE18D8Q29039267-C5571F5E-AA2A-4876-9B24-BF1F257B7CC7Q30277777-2FC22DB5-0E04-4596-A648-78F809CA6604Q30353313-41FB687F-7C7E-4DBB-B5AB-4B95AD4E8134Q30358000-34012222-E1DE-435A-89FB-ACFED8AEE0A4Q30414992-44368489-3F7E-4F2A-B940-4BB4C767AAF1Q30487910-8A86ED58-96EC-4937-A0C4-E2E265B72C98Q30651060-76F6862C-3769-4E09-9843-96533CAF2325Q33249524-67A84153-1AEE-4780-B205-72194AD37C32Q33669453-09A27E0B-BFE3-4461-BCA7-D8B448956340Q33719564-331609DC-A7C5-4787-BC79-2BDACC1ECDF6Q33719588-4F465BC0-B8F5-442B-9C7A-FA8FAA36791BQ33779874-5AABC4E8-E699-4755-A770-CCC57482B0A3Q33815745-DBB0067F-BDD5-4C20-AAB5-C3BD4489CF3BQ33816883-61CB8BB2-FE4A-4B60-A163-5E4A220FA871Q33834131-365944F3-7F68-4DEC-AF75-02F68ABEEF5FQ33888030-90D0520A-435C-41D6-BB02-8BDF486DE325Q33951428-27642706-9CA4-4FBE-9BA3-3AC9B3C291EEQ34377960-FB05501E-05D4-40E6-905F-A7EA73F025A7Q34409803-0ACEA098-16B3-4D8A-85C6-BD8DEFCFA504Q34415302-05EBDF7B-CB3C-4C12-9936-CF514D0E1EB8Q34469693-5CDD1DB7-A101-4BE7-BB46-BB07CB0B9556Q35173720-8A40A0CE-ADFF-4D92-A2FC-265C7A6EFF8FQ35625486-27EDD4DD-11FC-4052-B6F0-CAFBB7D03EDCQ35857721-35B10E93-C1EB-4C2E-8A68-114B528E22DFQ36120771-9AF49959-E3EC-4611-88F5-87E955E91E09Q36164350-A045D604-4CD1-4A39-B971-C7E71B542611Q36232937-A67A3873-560F-4FDB-A6DE-23FB32C9622AQ36312379-30DB4E47-8D3C-4EF0-87CA-30C9ACA7DBFBQ36329391-E79E431A-96E9-46BF-8A6B-74116739415C
P2860
Expression cloning and characterization of the canine parietal cell gastrin receptor.
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@ast
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@en
type
label
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@ast
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@en
prefLabel
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@ast
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@en
P2093
P2860
P356
P1476
Expression cloning and characterization of the canine parietal cell gastrin receptor.
@en
P2093
E W McBride
L F Kolakowski
L J Miller
M Beinborn
P2860
P304
P356
10.1073/PNAS.89.8.3605
P407
P577
1992-04-01T00:00:00Z